Kooman & Associates Johnson & Johnson Transaction History

Kooman & Associates

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$155.75 - $174.48 $208,393 - $233,454	-1,338 Closed	0 $0
Q2 2023 Nov 03, 2023	BUY	$154.35 - $166.11 $5,865 - $6,312	38 Added 2.92%	1,338 $221,000
Q2 2023 Jul 20, 2023	BUY	$154.35 - $166.11 $5,865 - $6,312	38 Added 2.92%	1,338 $221 Million
Q1 2023 Nov 03, 2023	SELL	$151.05 - $180.26 $5,286 - $6,309	-35 Reduced 2.62%	1,300 $202 Million
Q1 2023 Apr 21, 2023	SELL	$151.05 - $180.26 $5,286 - $6,309	-35 Reduced 2.62%	1,300 $202 Million
Q4 2022 Nov 03, 2023	SELL	$160.2 - $179.79 $480 - $539	-3 Reduced 0.22%	1,335 $236 Million
Q4 2022 Jan 24, 2023	BUY	$160.2 - $179.79 $213,866 - $240,019	1,335 New	1,335 $236 Million

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $419B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Kooman & Associates, based on Form 13F filings with the SEC.

Stay updated on Kooman & Associates with notifications on news.